ATE142627T1 - Methode zur verbesserung des schlafes - Google Patents
Methode zur verbesserung des schlafesInfo
- Publication number
- ATE142627T1 ATE142627T1 AT88200587T AT88200587T ATE142627T1 AT E142627 T1 ATE142627 T1 AT E142627T1 AT 88200587 T AT88200587 T AT 88200587T AT 88200587 T AT88200587 T AT 88200587T AT E142627 T1 ATE142627 T1 AT E142627T1
- Authority
- AT
- Austria
- Prior art keywords
- 6alkyl
- aminocarbonyl
- optionally substituted
- hydroxyc1
- chem
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Photolithography (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3412987A | 1987-04-01 | 1987-04-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE142627T1 true ATE142627T1 (de) | 1996-09-15 |
Family
ID=21874492
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT88200587T ATE142627T1 (de) | 1987-04-01 | 1988-03-29 | Methode zur verbesserung des schlafes |
AT96200236T ATE207474T1 (de) | 1987-04-01 | 1988-03-29 | Schlafverbesserungsmittel |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96200236T ATE207474T1 (de) | 1987-04-01 | 1988-03-29 | Schlafverbesserungsmittel |
Country Status (21)
Country | Link |
---|---|
EP (2) | EP0285219B1 (de) |
JP (1) | JP2574377B2 (de) |
KR (1) | KR960016539B1 (de) |
AT (2) | ATE142627T1 (de) |
AU (1) | AU609790B2 (de) |
CA (1) | CA1315790C (de) |
DE (2) | DE3856501T2 (de) |
DK (1) | DK174878B1 (de) |
ES (2) | ES2091183T3 (de) |
FI (1) | FI97617C (de) |
GR (1) | GR3020983T3 (de) |
HK (1) | HK1006020A1 (de) |
HU (2) | HUT57740A (de) |
IE (1) | IE81057B1 (de) |
IL (1) | IL85919A (de) |
NO (1) | NO178660C (de) |
NZ (1) | NZ223847A (de) |
PH (1) | PH25507A (de) |
PT (1) | PT87118B (de) |
RU (1) | RU2014328C1 (de) |
ZA (1) | ZA882352B (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5840896A (en) * | 1989-11-22 | 1998-11-24 | Janssen Pharmaceutica, N.V. | Method of preventing or limiting reperfusion damage |
JP2574585B2 (ja) * | 1989-11-22 | 1997-01-22 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 再潅流損傷の防止又は制限のための薬剤 |
JP2660086B2 (ja) * | 1990-07-03 | 1997-10-08 | 明治製菓株式会社 | 脳及び心機能障害改善剤 |
US5276035A (en) * | 1990-07-26 | 1994-01-04 | Novo Nordisk A/S | 1,4-disubstituted piperazines |
SE9202266D0 (sv) * | 1992-07-31 | 1992-07-31 | Kabi Pharmacia Ab | Novel piperazine carboxamides |
EP0582164B1 (de) * | 1992-07-31 | 1998-12-23 | Bristol-Myers Squibb Company | Diphenyl Oxazole-, Thiazole- und Imidazole-Derivate als Inhibitoren der Wiederaufnahme des Adenosins |
PT756593E (pt) * | 1994-04-20 | 2001-01-31 | Lonza Ag | Processo para a producao de derivados de acido 2-piperazinocarboxilico |
CA2234342A1 (en) * | 1997-04-10 | 1998-10-10 | Kyowa Hakko Kogyo Co., Ltd. | Pancreatitis remedy |
EP0999840B1 (de) | 1997-06-16 | 2003-05-02 | Janssen Pharmaceutica N.V. | Verwendung von einem draflazin analog zur schmerzbehandlung |
UA89503C2 (uk) | 2004-09-13 | 2010-02-10 | Х. Луннбек А/С | Заміщені похідні аніліну |
CA2596393C (en) | 2004-12-30 | 2014-09-23 | Janssen Pharmaceutica N.V. | 4-(benzyl)-piperazine-1-carboxylic acid phenylamide derivatives and related compounds as modulators of fatty acid amide hydrolase for the treatment of anxiety, pain and other conditions |
UA108233C2 (uk) | 2010-05-03 | 2015-04-10 | Модулятори активності гідролази амідів жирних кислот | |
CN110511220B (zh) * | 2018-05-22 | 2022-04-01 | 上海挚盟医药科技有限公司 | 作为钾通道调节剂的对二氨基苯衍生物、其制备方法及其在医药上的应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1795375A1 (de) * | 1968-09-21 | 1972-01-05 | Boehringer Mannheim Gmbh | Basische AEther und Verfahren zur Herstellung derselben |
US4766125A (en) * | 1981-06-23 | 1988-08-23 | Janssen Pharmaceutica N.V. | N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia |
-
1988
- 1988-03-10 NZ NZ223847A patent/NZ223847A/xx unknown
- 1988-03-16 CA CA000561610A patent/CA1315790C/en not_active Expired - Lifetime
- 1988-03-29 DE DE3856501T patent/DE3856501T2/de not_active Expired - Lifetime
- 1988-03-29 DE DE3855520T patent/DE3855520T2/de not_active Expired - Lifetime
- 1988-03-29 EP EP88200587A patent/EP0285219B1/de not_active Expired - Lifetime
- 1988-03-29 EP EP96200236A patent/EP0727421B1/de not_active Expired - Lifetime
- 1988-03-29 NO NO881407A patent/NO178660C/no not_active IP Right Cessation
- 1988-03-29 AU AU13847/88A patent/AU609790B2/en not_active Expired
- 1988-03-29 ES ES88200587T patent/ES2091183T3/es not_active Expired - Lifetime
- 1988-03-29 AT AT88200587T patent/ATE142627T1/de not_active IP Right Cessation
- 1988-03-29 ES ES96200236T patent/ES2167510T3/es not_active Expired - Lifetime
- 1988-03-29 AT AT96200236T patent/ATE207474T1/de not_active IP Right Cessation
- 1988-03-30 IL IL85919A patent/IL85919A/xx not_active IP Right Cessation
- 1988-03-30 PH PH36714A patent/PH25507A/en unknown
- 1988-03-30 PT PT87118A patent/PT87118B/pt not_active IP Right Cessation
- 1988-03-30 KR KR1019880003493A patent/KR960016539B1/ko not_active IP Right Cessation
- 1988-03-30 DK DK198801797A patent/DK174878B1/da not_active IP Right Cessation
- 1988-03-31 ZA ZA882352A patent/ZA882352B/xx unknown
- 1988-03-31 JP JP63076629A patent/JP2574377B2/ja not_active Expired - Lifetime
- 1988-03-31 FI FI881525A patent/FI97617C/fi not_active IP Right Cessation
- 1988-03-31 RU SU884355523A patent/RU2014328C1/ru active
- 1988-03-31 IE IE98988A patent/IE81057B1/en not_active IP Right Cessation
- 1988-03-31 HU HU881601A patent/HUT57740A/hu unknown
-
1995
- 1995-06-20 HU HU95P/P00287P patent/HU211129A9/hu unknown
-
1996
- 1996-09-12 GR GR960402273T patent/GR3020983T3/el unknown
-
1998
- 1998-06-11 HK HK98105168A patent/HK1006020A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3176010D1 (en) | Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids, salts thereof, pharmaceutical compositions containing the derivatives or salts, and the production of the same | |
HUT46708A (en) | Process for producing heterocyclic ketones and pharmaceutical compositions containing them as active components | |
HUT58322A (en) | Process for producing new n-(3-hydroxy-4-piperidinyl)-dihydro-benzofurane-, -dihydro-2h-penzopyrane- and -dihydro-benzodioxine-carboxamide derivatives and pharmaceutical compositions containing them | |
HUT50316A (en) | Process for production of 1-phenyl-3-naphthyl-oxy-propanamines and pharmaceutical preparations containing them | |
DE3855520D1 (de) | Methode zur Verbesserung des Schlafes | |
HUT40101A (en) | Process for producing quinolin-carboxylic acid derivatives and pharmaceutical compositions containing them as active agents | |
IE890177L (en) | Piperidinyl derivatives | |
HU891462D0 (en) | Process for the preparation of novel compounds | |
JPS6442472A (en) | Quinazoline derivative, production thereof and brain function disorder improving agent containing said derivative as active ingredient | |
DK0398427T3 (da) | Antirhinovirale pyridazinaminer | |
FI894125A0 (fi) | Analogiamenetelmä terapeuttisesti käyttökelpoisen 3-piperidinyyli-indatsolin valmistamiseksi | |
DK158513C (da) | N-(substitueret phenyl)-n'-pyridinylurinstoffer, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse | |
ATE105476T1 (de) | Dihydropyridin-verbindung zur verbesserung der adernausdehnung und hemmung der herzhypertrophie. | |
JPS5673047A (en) | Decaprenylamine derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
EELA | Cancelled due to lapse of time |